$0.00040
-0.11-99.64%
Last update: Oct 23, 10:46 AM
WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT) Stock Price, Quote, News & History
WINTOTCEM
Publicly traded companies are increasingly integrating cryptocurrencies other than Bitcoin (CRYPTO: BTC), into their treasuries, with significant investments...
You can purchase shares of WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (OTCEM:WINT) through any online brokerage.
There are no as such competitors for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc..
WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. has a consensus price target of $350.00.
The stock price for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (OTCEM: WINT) is $0.0004 last updated October 23, 2026 at 10:46 AM EDT.
There are no upcoming dividends for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc..
WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc..
WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic...
